SCHEMBL1812652

SCHEMBL1812652

CCOC(=O)C=C1CCCCC1C#N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.39
CYP2D6 P10635 1/20 0.35
TSHR P16473 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
LMNA P02545 2/20 0.33
BCHE P06276 1/20 0.33
ALDH1A1 P00352 7/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
HSD17B10 Q99714 3/20 0.33
KDM4E B2RXH2 2/20 0.33
RECQL P46063 2/20 0.33
HPGD P15428 2/20 0.33
KMT2A Q03164 4/20 0.32
NPC1 O15118 3/20 0.32
RAB9A P51151 3/20 0.32
MAPT P10636 3/20 0.32
MEN1 O00255 2/20 0.32
GAA P10253 1/20 0.32
CYP2C9 P11712 1/20 0.32
POLB P06746 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1812651 1.00 ESR2 (0.39) ESR2CYP2D6TSHRNPSR1LMNA
SCHEMBL19031254 0.83 ALDH1A1 (0.36) NPSR1LMNAALDH1A1SMN1; SMN2KMT2A
SCHEMBL7572218 0.79 DPP4 (0.35) NPSR1LMNAALDH1A1SMN1; SMN2HPGD
SCHEMBL13181696 0.77 CYP2D6 (0.40) ESR2CYP2D6NPSR1LMNAALDH1A1
SCHEMBL20599694 0.77 ESR2 (0.41) ESR2CYP2D6NPSR1LMNABCHE
SCHEMBL5909622 0.74 ESR2 (0.34) ESR2NPSR1LMNABCHEALDH1A1
SCHEMBL3812188 0.74 ESR2 (0.42) ESR2CYP2D6TSHRNPSR1LMNA
SCHEMBL11041444 0.74 CYP2D6 (0.43) ESR2CYP2D6TSHRNPSR1BCHE
SCHEMBL20400492 0.72 SLC6A2 (0.32) TSHRLMNASMN1; SMN2
SCHEMBL1900997 0.72 ESR2 (0.55) ESR2CYP2D6TSHRNPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011061590-A1 NOVEL CARBOXAMIDE DERIVATIVES AS HIV INHIBITORS HETERO RESEARCH FOUNDATION (IN) 2011-05-26 WO disclosed